Cargando…

Correction to: Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study

Detalles Bibliográficos
Autores principales:	Yamada, Hideyasu, Matsumoto, Isao, Makita, Naoyuki, Arita, Yoshifumi, Hayashi, Nobuya, Mitsuoka, Kurena, Tashiro, Naoki, Hizawa, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641768/ https://www.ncbi.nlm.nih.gov/pubmed/36345030 http://dx.doi.org/10.1186/s12931-022-02219-y

Ejemplares similares

Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study
por: Yamada, Hideyasu, et al.
Publicado: (2022)

Correction: Real-World Status of Medical Care and Treatment of Chronic Obstructive Pulmonary Disease by Respiratory Specialists in Japan
por: Hashimoto, Shu, et al.
Publicado: (2022)

Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
por: Tanaka, Akihiko, et al.
Publicado: (2023)

Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study
por: Hashimoto, Shu, et al.
Publicado: (2023)

Real-World Status of Medical Care and Treatment of Chronic Obstructive Pulmonary Disease by Respiratory Specialists in Japan
por: Hashimoto, Shu, et al.
Publicado: (2022)

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease
por: Beeh, Kai M.
Publicado: (2016)

Relationship between lung function and inhalation devices for LAMA/LABA therapy for chronic obstructive pulmonary disease
por: Yamada, Hideyasu, et al.
Publicado: (2017)

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
por: Yamada, Hideyasu, et al.
Publicado: (2018)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Correction: The Cellular and Molecular Basis of Bitter Tastant-Induced Bronchodilation
por: Zhang, Cheng-Hai, et al.
Publicado: (2013)

Correction to: Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis
por: Ismaila, Afisi S., et al.
Publicado: (2022)

Characterization of Severe Uncontrolled Asthma in Japan: Analysis of Baseline Data from the PROSPECT Study
por: Koya, Toshiyuki, et al.
Publicado: (2023)

Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
por: Kopsaftis, Zoe A., et al.
Publicado: (2018)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
por: Kim, Junghyun, et al.
Publicado: (2017)

A case of a pulmonary artery sling misdiagnosed as refractory asthma for 20 years
por: Inui, Toshihide, et al.
Publicado: (2017)

Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach
por: Singh, Dave, et al.
Publicado: (2023)

Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007)

The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Bronchodilator Response Assessment of the Small Airways Obstructive Pattern
por: Bokov, Plamen, et al.
Publicado: (2017)

The search for common pathways underlying asthma and COPD
por: Kaneko, Yoshiko, et al.
Publicado: (2013)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
por: Naya, Ian, et al.
Publicado: (2019)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
por: Bengtson, Lindsay G.S., et al.
Publicado: (2018)

Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
por: Di Marco, Fabiano, et al.
Publicado: (2018)

Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD)
por: Hyodo, Kentaro, et al.
Publicado: (2022)

Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma
por: Yamada, Hideyasu, et al.
Publicado: (2021)

Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2008)

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease
por: van der Vaart, Hester, et al.
Publicado: (2011)

Bronchodilator-responsive bronchiolar obstruction in term neonates: a case series
por: Ezenwa, Beatrice N., et al.
Publicado: (2023)

Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit
por: Okauchi, Shinichiro, et al.
Publicado: (2019)

Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

Correction to: Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease
por: Joo, Hyonsoo, et al.
Publicado: (2021)

Bronchodilator effect of deep inspiration and bronchoconstriction-triggered cough
por: Ohkura, Noriyuki, et al.
Publicado: (2009)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
por: Donohue, James F, et al.
Publicado: (2011)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma
por: Vilozni, Daphna, et al.
Publicado: (2016)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lrd8a5nelgk1gp916g0007bte3